What is RAPID?

RAPID stands for Retinal Anti-VEGF Program for Intraocular Disease. It was developed by the retinal specialists of Alberta in collaboration with the Government of Alberta.

Treatment

Several retinal diseases are treated with medications injected into the eye at regular intervals. These drugs fall into the category of "Anti-VEGF" agents (Anti-Vascular Endothelial Growth Factor).

Diseases Treated

The common diseases treated with injections include macular degeneration, diabetic retinopathy, and vein occlusions. In most cases, repeat injections with costly drugs are given over months and even years.

Importance of Treatment

Without treatment, vision loss can be severe and permanent.

Goals of RAPID

• To improve access to all age categories of patients
• To improve vision outcomes of all Albertans
• To safeguard patient safety by monitoring risks and complications
• To reduce the cost for all Albertans

Available Medications

Currently, three medications are available through this program:

• Avastin (Bevacizumab)
• Lucentis (Ranibizumab)
• Eylea (Aflibercept)